Wealth Effects’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Wealth Effects's FBT Position: Q2 2026 in Review
Wealth Effects increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3.9% in Q2 2026, buying an estimated $21.5K and bringing the position to 2,685 shares worth $666K. The position accounts for 0.18% of the portfolio, ranked #101.
Wealth Effects first reported a position in FBT in Q4 2021 and has held it in 19 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Wealth Effects held 2,685 shares of First Trust NYSE Arca Biotechnology Index Fund worth $666K as of Q2 2026.
- Wealth Effects bought 100 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $21.5K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.18% of Wealth Effects's portfolio in Q2 2026, its #101 holding.
- Wealth Effects first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and has held it in 19 quarters since.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Wealth Effects's 13F filing for Q2 2026, filed 6 Aug 2026.